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Review of Pulmonary Effects of Poly(vinyl
Chloride) and Vinyl Chloride Exposure
by Ruth Lilis*
The contributions of several recent reports to the definition of pulmonary effects of PVC dust
inhalation are reviewed. Granulomatous reaction, with inclusion of PVC particles in macro-
phages and histocytes, and associated interstitial pulmonary fibrosis have been found to lead to
exertional dyspnoea, diffuse micronodular chest radiographic opacities and restrictive pulmo-
nary dysfunction.
The effects of vinyl chloride (VC) monomer (gas) on proteins and the immunologic
mechanisms triggered by the altered protein are possible mechanisms for the development in
some cases of interstitial pulmonary fibrosis secondary to VC exposure.
Vinyl chloride, a confirmed carcinogen, has been associated with, among other malignant
tumors, a significant increase in the incidence of lung cancer. The magnitude of this effect has
not yet been completely evaluated.
Several recent reports (1-3) have contributed
new observations on pulmonary disease in vinyl
chloride (VC)- and poly(vinyl chloride) (PVC)-
exposed patients.
Earlier reports, a few even preceding the
identification in 1974 of vinyl chloride as a human
carcinogen (with hemangiosarcoma of the liver the
marker tumor, but most probably not the only
tumor), had centered on the rather unexpected
occurrence of pulmonary radiologic abnormalities
(4-8) or pulmonary function impairment (4, 9-12) or
had indicated dyspnea as aprominent symptom (11,
13) in VC and/or PVC exposed workers.
The radiologic pattern first described in 1975 (5)
was essentially that ofreticular-linear and/or nodu-
lar (small rounded) opacities, involving both lungs,
predominantly in the lower zones.
Pulmonary function abnormalities reported have
been both restrictive and obstructive dysfunction
with diffusion defects and arterial desaturation in
some cases.
Three recent reports, one a case report (1), the
other two epidemiologic surveys (2, 3), seem to
identify PVC dust as the etiologic agent in a
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peculiar type ofpulmonary fibrosis associated with
a granulomatous reaction.
Exertional dyspnea, diffuse micronodular chest
radiographic abnormalities and restrictive pulmo-
nary dysfunction, were the main characteristics in
the case ofPVC pulmonary fibrosis associated with
granulomatous lesions (1).
Electron microscopic examination of lung tissue
showed giant multinucleated cells containing a
nonhomogeneous material in their cytoplasm, which
was identified to be PVC (1). A similar pattern was
reproduced by incubation of human macrophages
obtained by bronchial lavage, with PVC powder:
absorption of PVC particles in the cytoplasm was
rapid, with thinly granular lysosomal material de-
posited against the PVC particles.
Similar histologic lesions had been previously
described in a human case (4) and in an experimen-
tal study in guinea pigs and rats (14). In another
experimental study, intratracheal administration of
PVC dust in rats (15) has been shown toresult in an
increase in the activity of lysosomal enzymes,
interstitial fibrosis and granulomatous lesions sur-
rounded byfibroblasts, reticulin and collagen fibers.
An epidemiologic study of a large group of
workers exposed to PVC and VC (2) detected 20
cases of "typical pneumoconiosis," i.e., chest x-ray
changes consisting in irregular opacities or
micronodular shadows of at least class 1 profusion,
167according to the ILO U/C Classification. All these
cases were found among PVC exposed employees.
The pattern ofradiologic abnormalities described is
very similar to that reported in the case in which
the lung biopsy revealed fibrosis and granuloma-
tous reaction, with inclusion of PVC particles.
The same study reported the presence of less
marked radiologic abnormalities, of the linear-
reticular type, in a much larger proportion (32%) of
the population examined; these changes were pres-
ent both in VC monomer exposed and in PVC
exposed employees. While the prevalence was
higher in smokers than nonsmokers, 65 of the 388
x-rays with linear-reticular opacities were found in
persons who had never smoked.
In another large epidemiologic study (3), expo-
sure to respirable PVC dust was found to be
associated in a proportion ofexposed workers with
the presence ofsmall rounded opacities onthe chest
radiograph and a decline in mean ventilatory capac-
ity.
The question of pulmonary effects due to vinyl
chloride monomer continues to be ofgreat interest.
The multi-organ effects ofvinyl chloride include the
peculiar syndrome of acroosteolysis, scleroderma-
like skin changes, vascular changes affecting the
arteries, arterioles and capillaries of hands and
fingers, liver and spleen capsular fibrosis, liver
fibrosis, abnormalities of the sinusoidal vessels in
the liver, and portal hypertension. Ward (16) inves-
tigated the immunologic status of 58 workers from
a VC polymerization plant. The findings included
hyperimmunoglobulinemia, cryoglobulinemia, cryo-
fibrinogenemia, in vivo complement activation via
the classic pathway, with C4 and C3 conversion and
an increase in the B cell lymphocyte population.
Immunofluorescent examination of skin, muscle
and lungbiopsy specimens revealed the presence of
circulating immune complexes, with deposition on
the vascular endothelium and occlusion of small
vessels. Immunoglobulin, complementandfibrinogen
deposition in the subintimal regions of the vessel
were found in areas with subintimal fibrosis and
luminal occlusion.
Grainger et al. (17) have accumulated evidence
suggesting the following mechanism: the vinyl
chloride metabolite cyclic chlorethylene epoxide, an
alkylating agent with high biological activity binds
to IgGproducing structural conformational changes
that promote aggregation of IgG molecules. The
modified IgG may also become antigenic. The IgG
aggregates are cryoprecipitable and may initiate
complement activation. Precipitation ofIgG aggre-
gates by cold leads to complement activation,
platelet aggregation and conversion offibrinogen to
fibrin with polymerization. Occlusion of small ves-
sels results, and ischemia stimulates new collagen
biosynthesis.
Similar abnormalities of the immunologic status
were found in another study of22 workers exposed
to vinyl chloride, with Raynaud's syndrome and, in
some cases, acroosteolysis. Latent cryoglobulinemia
was detected in 18 cases, with increases ofimmunu-
noglobulins, IgA and IgG (18).
Circulating cryoimmunoglobulins are a promi-
nent feature of idiopathic pulmonary fibrosis (19)
and increased IgG levels have been shown to be
characteristic for bronchoalveolar lavage fluid of
such patients.
Interstitial pulmonary fibrosis is a possible effect
of vinyl chloride exposure. The occurrence ofmore
dramatic and specific abnormalities in other organ
systems-liver, spleen and peripheralcirculation
has probably prevented more focused attention on
pulmonary effects of vinyl chloride in the past.
Long-term effects of vinyl chloride include well
documented carcinogenicity. Lung cancer has been
found to occur with an increased incidence in
several mortality studies (20-22). Abnormalities in
sputum cytology tests have been found to be more
frequent in VC/PVC-exposed workersthan in other
chemical industry employees and in smokers (23).
In experiments on mice, Suzuki (24) has described
hyperplastic changes ofthe alveolar lining cells and
pulmonary tumors in the majority of exposed
animals. The ultrastructure was thought to indicate
that the tumors originated in type II alveolar cells.
Alveologenic tumors were also described in several
other experimental studies (25-27). Interestingly,
other known carcinogens, such as polycyclic aro-
matic hydrocarbons, nitrogen mustard and chro-
mates, produce pulmonary tumors in experimental
animals similarly, originatinginthe type II alveolar
cell.
The effects of vinyl chloride-poly(vinyl chloride)
exposure on the respiratory system of exposed
workers seem to indicate two patterns ofnonmalig-
nant effects: a granulomatous reaction to PVC
dust, with inclusion of PVC particles in macro-
phages and histocytes and associated interstitial
fibrosis, and an interstitial pulmonary fibrosis due
to vinyl chloride monomer effects on protein mole-
cules and the immunologic mechanisms triggered
by the altered protein.
Thelong-termcarcinogeniceffect, withasignificant
increase in the incidence of lung cancer, also is of
concern, although the magnitude of this effect has
not yet been completely evaluated.
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